Clinical trial
Tumor Response Assessment by MRI Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
NCT03088423 is registered in ClinicalTrials.gov with Institut de Cancérologie de Lorraine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tumor Response Assessment by MRI Following Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
- Lead sponsor
- Institut de Cancérologie de Lorraine
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 1, 2011
- Completion date
- February 1, 2015
- Enrollment
- 35 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.